EP3154536
XPO1 ANTAGONIST KPT-251 FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROME
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
9.6.2015EP published:
1.11.2023EP application number:
15731531.8
EPO information:
European Patent Register
Max expiry date:
8.6.2035
Title in English:
XPO1 ANTAGONIST KPT-251 FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROMELanguage of the patent:
English
Timeline
Today
9.6.2015EP application
1.11.2023EP Publication
Owner
Name:
Institut National de la Santé et de la Recherche Médicale (INSERM)Address:
101, rue de Tolbiac, 75013 Paris, FR
Name:
Fondation ImagineAddress:
24, Boulevard du Montparnasse, 75015 Paris, FR
Name:
Assistance Publique-Hôpitaux de Paris (APHP)Address:
3, avenue Victoria, 75004 Paris, FR
Name:
Université Paris CitéAddress:
85 boulevard Saint-Germain, 75006 Paris, FR
Name:
Centre National de la Recherche Scientifique (C.N.R.S.)Address:
3, rue Michel-Ange, 75016 Paris, FR
Inventor
Name:
HERMINE, OlivierAddress:
75015 Paris, FR
Name:
ARLET, Jean-BenoitAddress:
75015 Paris, FR
Name:
GUILLEM, FlaviaAddress:
75015 Paris, FR
Name:
COURTOIS, GenevèveAddress:
75015 Paris, FR
Name:
FONTENAY, MichaelaAddress:
75014 Paris, FR
Priority
Number:
14305873Date:
10.6.2014Country:
EP
Classification
Categories:
A61K 31/422, A61P 35/02